Therapeutic Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats

Badreldin H. Ali, Mohammed Al Za'abi, Sirin A. Adham, Javed Yasin, Abderrahim Nemmar, Nicole Schupp

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background/Aims: To study the therapeutic effect of chrysin, a flavonoid with strong antioxidant and anti-inflammatory activities, on adenine-induced chronic kidney diseases (CKD) in rats. Methods: Chrysin, in three graded oral doses (10, 50 and 250 mg/kg), was given for 10 consecutive days to rats after the induction of CKD by feeding them adenine (0.25%w/w for 35 days). Several plasma and urine biomarkers and tissues morphology were used the investigate chrysin effect on kidney structure and function. Results: Adenine lowered creatinine clearance and elevated the concentrations of urea, creatinine, plasma neutrophil gelatinase-associated lipocalin and urinary N-Acetyl-beta-D-glucosaminidase activity, and increased the concentrations of the uremic toxin indoxyl sulfate, in addition to some inflammatory cytokines. Renal histopathological markers of inflammation and fibrosis were significantly increased. Renal catalase and superoxide dismutase activities, total antioxidant capacity and reduced glutathione were all adversely affected. Most of these adenine - induced actions were moderately mitigated by chrysin, especially at the highest dose. Compared to control, chrysin did not cause any overt adverse effects on the treated rats. Conclusion: Different doses of chrysin produce variable therapeutic salutary effects in rats with CKD, and that, pending further studies, its usability as a possible therapeutic agent in human CKD should be considered.

Original languageEnglish
Pages (from-to)248-257
Number of pages10
JournalCellular Physiology and Biochemistry
DOIs
Publication statusAccepted/In press - Jan 20 2016

Fingerprint

Therapeutic Uses
Adenine
Chronic Renal Insufficiency
Kidney
Creatinine
Indican
Antioxidants
Acetylglucosaminidase
Flavonoids
Catalase
Superoxide Dismutase
Glutathione
Urea
chrysin
Fibrosis
Anti-Inflammatory Agents
Biomarkers
Urine
Cytokines
Inflammation

Keywords

  • Adenine
  • Chronic kidney disease
  • Chrysin
  • Inflammation#
  • Oxidative damage
  • Rat

ASJC Scopus subject areas

  • Physiology

Cite this

Therapeutic Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats. / Ali, Badreldin H.; Al Za'abi, Mohammed; Adham, Sirin A.; Yasin, Javed; Nemmar, Abderrahim; Schupp, Nicole.

In: Cellular Physiology and Biochemistry, 20.01.2016, p. 248-257.

Research output: Contribution to journalArticle

@article{f21d354490bb4168a9fbd6ee8d55938b,
title = "Therapeutic Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats",
abstract = "Background/Aims: To study the therapeutic effect of chrysin, a flavonoid with strong antioxidant and anti-inflammatory activities, on adenine-induced chronic kidney diseases (CKD) in rats. Methods: Chrysin, in three graded oral doses (10, 50 and 250 mg/kg), was given for 10 consecutive days to rats after the induction of CKD by feeding them adenine (0.25{\%}w/w for 35 days). Several plasma and urine biomarkers and tissues morphology were used the investigate chrysin effect on kidney structure and function. Results: Adenine lowered creatinine clearance and elevated the concentrations of urea, creatinine, plasma neutrophil gelatinase-associated lipocalin and urinary N-Acetyl-beta-D-glucosaminidase activity, and increased the concentrations of the uremic toxin indoxyl sulfate, in addition to some inflammatory cytokines. Renal histopathological markers of inflammation and fibrosis were significantly increased. Renal catalase and superoxide dismutase activities, total antioxidant capacity and reduced glutathione were all adversely affected. Most of these adenine - induced actions were moderately mitigated by chrysin, especially at the highest dose. Compared to control, chrysin did not cause any overt adverse effects on the treated rats. Conclusion: Different doses of chrysin produce variable therapeutic salutary effects in rats with CKD, and that, pending further studies, its usability as a possible therapeutic agent in human CKD should be considered.",
keywords = "Adenine, Chronic kidney disease, Chrysin, Inflammation#, Oxidative damage, Rat",
author = "Ali, {Badreldin H.} and {Al Za'abi}, Mohammed and Adham, {Sirin A.} and Javed Yasin and Abderrahim Nemmar and Nicole Schupp",
year = "2016",
month = "1",
day = "20",
doi = "10.1159/000438626",
language = "English",
pages = "248--257",
journal = "Cellular Physiology and Biochemistry",
issn = "1015-8987",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Therapeutic Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats

AU - Ali, Badreldin H.

AU - Al Za'abi, Mohammed

AU - Adham, Sirin A.

AU - Yasin, Javed

AU - Nemmar, Abderrahim

AU - Schupp, Nicole

PY - 2016/1/20

Y1 - 2016/1/20

N2 - Background/Aims: To study the therapeutic effect of chrysin, a flavonoid with strong antioxidant and anti-inflammatory activities, on adenine-induced chronic kidney diseases (CKD) in rats. Methods: Chrysin, in three graded oral doses (10, 50 and 250 mg/kg), was given for 10 consecutive days to rats after the induction of CKD by feeding them adenine (0.25%w/w for 35 days). Several plasma and urine biomarkers and tissues morphology were used the investigate chrysin effect on kidney structure and function. Results: Adenine lowered creatinine clearance and elevated the concentrations of urea, creatinine, plasma neutrophil gelatinase-associated lipocalin and urinary N-Acetyl-beta-D-glucosaminidase activity, and increased the concentrations of the uremic toxin indoxyl sulfate, in addition to some inflammatory cytokines. Renal histopathological markers of inflammation and fibrosis were significantly increased. Renal catalase and superoxide dismutase activities, total antioxidant capacity and reduced glutathione were all adversely affected. Most of these adenine - induced actions were moderately mitigated by chrysin, especially at the highest dose. Compared to control, chrysin did not cause any overt adverse effects on the treated rats. Conclusion: Different doses of chrysin produce variable therapeutic salutary effects in rats with CKD, and that, pending further studies, its usability as a possible therapeutic agent in human CKD should be considered.

AB - Background/Aims: To study the therapeutic effect of chrysin, a flavonoid with strong antioxidant and anti-inflammatory activities, on adenine-induced chronic kidney diseases (CKD) in rats. Methods: Chrysin, in three graded oral doses (10, 50 and 250 mg/kg), was given for 10 consecutive days to rats after the induction of CKD by feeding them adenine (0.25%w/w for 35 days). Several plasma and urine biomarkers and tissues morphology were used the investigate chrysin effect on kidney structure and function. Results: Adenine lowered creatinine clearance and elevated the concentrations of urea, creatinine, plasma neutrophil gelatinase-associated lipocalin and urinary N-Acetyl-beta-D-glucosaminidase activity, and increased the concentrations of the uremic toxin indoxyl sulfate, in addition to some inflammatory cytokines. Renal histopathological markers of inflammation and fibrosis were significantly increased. Renal catalase and superoxide dismutase activities, total antioxidant capacity and reduced glutathione were all adversely affected. Most of these adenine - induced actions were moderately mitigated by chrysin, especially at the highest dose. Compared to control, chrysin did not cause any overt adverse effects on the treated rats. Conclusion: Different doses of chrysin produce variable therapeutic salutary effects in rats with CKD, and that, pending further studies, its usability as a possible therapeutic agent in human CKD should be considered.

KW - Adenine

KW - Chronic kidney disease

KW - Chrysin

KW - Inflammation#

KW - Oxidative damage

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=84955576807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955576807&partnerID=8YFLogxK

U2 - 10.1159/000438626

DO - 10.1159/000438626

M3 - Article

SP - 248

EP - 257

JO - Cellular Physiology and Biochemistry

JF - Cellular Physiology and Biochemistry

SN - 1015-8987

ER -